| APTES | (3-Aminopropyl)triethoxysilane |
| CV | Carvacrol |
| C. parvum | Cryptosporidium parvum |
| DMF | N,N-Dimethylformamide |
| MSN | Mesoporous silicate nanoparticles |
| MTT | (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) |
| TEOS | Tetraethyl orthosilicate |
| APTES | (3-Aminopropyl)triethoxysilane |
| CV | Carvacrol |
| C. parvum | Cryptosporidium parvum |
| DMF | N,N-Dimethylformamide |
| MSN | Mesoporous silicate nanoparticles |
| MTT | (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) |
| TEOS | Tetraethyl orthosilicate |